Latest Stem cells Stories
A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson's disease, epilepsy, and possibly even Alzheimer's disease, as well as and complications of spinal cord injury such as chronic pain and spasticity. "We think this one type of cell may be useful in treating several types of neurodevelopmental and...
Dr. Eva Feldman and Ted Harada to discuss Neuralstem ALS Trial ROCKVILLE, Md., May 8, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, MD, PhD, principal investigator of the Phase II trial using NSI-566 spinal cord-derived human neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), will be a guest on Sirius XM's Doctor Radio station, channel 81, on Thursday, May 9, 10-11am EDT. Dr. Feldman will be on...
The human body contains trillions of cells, all derived from a single cell, or zygote, made by the fusion of an egg and a sperm. That single cell contains all the genetic information needed to develop into a human, and passes identical copies of that information to each new cell as it divides into the many diverse types of cells that make up a complex organism like a human being. If each cell is genetically identical, however, how does it grow to be a skin, blood, nerve, bone or other type...
In the news release, BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting, issued 06-May-2013 by BioLife Solutions, Inc. over PR Newswire, we are advised by the company that the meeting date in the first paragraph should read "April 22 - 25" rather than "June 22 - 25." The complete, corrected release follows: BioLife Solutions Announces Participation and Additional Product Citations at 19th ISCT Annual Meeting Continued Adoption of...
Continued Adoption of CryoStor® and HypoThermosol® in Clinical Applications BOTHELL, Wash., May 6, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today provided an overview of the Company's participation at the 19(th) Annual Meeting of the International Society for Cellular...
World Stem Cells Clinic in Cancun is pleased to announce the appointment of Dr. Ernesto Gutierrez to the position of President of their medical lab and treatment center. Dr. Gutierrez brings experience and intensity to his new position at World Stem Cells Clinic and promises he and his team of experts will provide the best medical care available in the world to improve their patient’s quality of life. Tampa, FL (PRWEB) May 04, 2013 World Stem Cells Clinic in Cancun is pleased to...
Brett Smith for redOrbit.com – Your Universe Online When geneticists at the University of Minnesota began work on what they thought was a regulatory gene, they probably had no idea their work would redefine the tiny snippet of genetic material as a key player in stem cell differentiation. According to the team’s report in the journal Cell Stem Cell, the gene Mesp1 is responsible for differentiation of heart, blood and muscle cells from stem cells. “Previous research indicated...
Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert Sullivan, PhD, dean of the Rady School of Management at the University of California, San Diego (UC San Diego) has agreed to join the Company’s Business Advisory Board. Dr. Sullivan is an expert on entrepreneurship, knowledge management and operations management. San Diego, CA (PRWEB) May 02, 2013 Stemedica Cell Technologies, Inc., a leader in...
Relumins, a brand that is always on the cutting edge of pharmaceutical-grade skincare, has developed a cream that does it all. Asbury Park, NJ (PRWEB) May 02, 2013 Relumins, a brand that is always on the cutting edge of pharmaceutical-grade skincare, has developed a cream that does it all. The Relumins scientists and product engineers, who have access to world-class data and research, have created a TA – Stem cell day cream to target signs of skin aging. So what is TA- Stem Cell therapy...
NEW YORK, May 2, 2013 /PRNewswire/ -- The seventh annual Delete Blood Cancer Gala held on May 1 at Cipriani Wall Street broke all records of previous years and raised $3.7 million to support the fight against leukemia and other blood-related cancers. The money raised jointly by Coty Inc., a leading global beauty company, and Delete Blood Cancer, part of the world's largest bone marrow donor center, will help register 55,000 new bone marrow donors and help patients worldwide. Over the...
